4.7 Article

Familial Prion Disease with Alzheimer Disease-Like Tau Pathology and Clinical Phenotype

期刊

ANNALS OF NEUROLOGY
卷 69, 期 4, 页码 712-720

出版社

WILEY-BLACKWELL
DOI: 10.1002/ana.22264

关键词

-

资金

  1. US Department of Veterans Affairs, Office of Research and Development
  2. National Institutes of Health (NIH)/National Institute on Aging (NIA) [2P50AG005136-27, 5P50NS062684-02, 5R01NS051480-05, 5P30AG010133-20]
  3. Athena Diagnostics

向作者/读者索取更多资源

Objective: To describe the Alzheimer disease (AD)-like clinical and pathological features, including marked neurofibrillary tangle (NFT) pathology, of a familial prion disease due to a rare nonsense mutation of the prion gene (PRNP). Methods: Longitudinal clinical assessments were available for the proband and her mother. After death, both underwent neuropathological evaluation. PRNP was sequenced after failure to find immunopositive A beta deposits in the proband and the documentation of prion protein (PrP) immunopositive pathology. Results: The proband presented at age 42 years with a 3-year history of progressive short-term memory impairment and depression. Neuropsychological testing found impaired memory performance, with relatively preserved attention and construction. She was diagnosed with AD and died at age 47 years. Neuropathologic evaluation revealed extensive limbic and neocortical NFT formation and neuritic plaques consistent with a Braak stage of VI. The NFTs were immunopositive, with multiple tau antibodies, and electron microscopy revealed paired helical filaments. However, the neuritic plaques were immunonegative for A beta, whereas immunostaining for PrP was positive. The mother of the proband had a similar presentation, including depression, and had been diagnosed clinically and pathologically as AD. Reevaluation of her brain tissue confirmed similar tau and PrP immunostaining findings. Genetic analysis revealed that both the proband and her mother had a rare PRNP mutation (Q160X) that resulted in the production of truncated PrP. Interpretation: We suggest that PRNP mutations that result in a truncation of PrP lead to a prolonged clinical course consistent with a clinical diagnosis of AD and severe AD-like NFTs. ANN NEUROL 2011; 69: 712-720

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据